Chemours Co (CC)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 11:04 AM ET
Chemours Co (CC) Stock Forecast
Analysts expect Chemours (CC) to earn $0.81 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.93B. Of 10 analysts, 2 rate the stock Buy or Strong Buy, 8 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.72.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.80, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 2 | 20.0% |
| Hold | 8 | 80.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 112.3% and revenue estimates rise 3.5%.
- Fiscal year ending Dec 31, 2026
- $0.81
- EPS consensus, revenue $5.93B
- Fiscal year ending Dec 31, 2027
- $1.72
- EPS consensus, revenue $6.14B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.81 | $0.75 to $0.85 | 10 | $5.93B | $5.91B to $5.96B | 9 |
| Dec 31, 2027 | $1.72 | $1.40 to $2.00 | 10 | $6.14B | $5.96B to $6.40B | 9 |
Quarterly Estimates
The EPS consensus rises from $0.14 for the quarter ending Dec 31, 2026 to $0.27 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.14 | $0.08 to $0.20 | 14 | $1.46B | $1.37B to $1.52B | 12 |
| Mar 31, 2027 | $0.27 | $0.23 to $0.34 | 5 | $1.43B | $1.41B to $1.44B | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 1 | 3 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 6.9% from $0.87.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.81 | $0.95 | $0.98 | $1.01 | $0.87 | -6.9% |
| Fiscal year ending Dec 31, 2027 | $1.72 | $1.86 | $1.91 | $1.93 | $2.01 | -14.4% |
| Quarter ending Mar 31, 2027 | $0.27 | $0.32 | $0.31 | $0.33 | $0.41 | -32.8% |
Frequently Asked Questions About CC
What is the CC stock forecast?
Consensus analyst estimates put Chemours's EPS at $0.81 for the fiscal year ending Dec 31, 2026, on revenue of $5.93B. The consensus rating from 10 analysts is Hold.
How do analysts rate CC stock?
Of 10 analysts covering Chemours, 0 rate it Strong Buy, 2 Buy, 8 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.81, with estimates from $0.75 to $0.85 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.72, with estimates from $1.40 to $2.00 from 10 analysts.
What revenue do analysts expect from Chemours next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.93B, with estimates from $5.91B to $5.96B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.14B, with estimates from $5.96B to $6.40B.
How many analysts cover CC?
10 analysts rate Chemours stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors